FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Glyburide Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Zydus Pharmaceuticals USA Inc. (New 05/22/2017)

Company Contact Information:
877-993-8779

Presentation Posting Date Related Information
Glyburide Tablets USP, 1.25mg, 100s (NDC 68382-656-01) 05/22/2017 The product is being discontinued because of commercial reasons.
Glyburide Tablets USP, 2.5mg, 100s (NDC 68382-657-01) 05/22/2017 The product is being discontinued because of commercial reasons.
Glyburide Tablets USP, 2.5mg, 500s (NDC 68382-657-05) 05/22/2017 The product is being discontinued because of commercial reasons.
Glyburide Tablets USP, 5mg, 100s (NDC 68382-658-01) 05/22/2017 The product is being discontinued because of commercial reasons.
Glyburide Tablets USP, 5mg, 1000s (NDC 68382-658-10) 05/22/2017 The product is being discontinued because of commercial reasons.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English